Associated Papers
Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia.
Hudkins RL et al.
Journal of Medicinal Chemistry, 2024
39258897 (PubMed )
Supplement: jm4c01531_si_001.pdf
Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation.
Chen L et al.
Nature Chemical Biology, 2020
Rotational Freedom, Steric Hindrance, and Protein Dynamics Explain BLU554 Selectivity for the Hinge Cysteine of FGFR4.
Lin X et al.
Acs Medicinal Chemistry Letters, 2019
31413803 (PubMed )
Supplement: ml9b00196_si_001.pdf
Select a paper to view details